co-infections

What people living with HIV need to know about HIV and COVID-19

COVID-19 is a serious disease and all people living with HIV should take all recommended preventive measures to minimize exposure to, and prevent infection by, the virus that causes COVID-19. As in the general population, older people living with HIV or people living with HIV with heart or lung problems may be at a higher risk of becoming infected with the virus and of suffering more serious symptoms.

Access the report infographic for a one-page summary.

Include in home page features rotation
Off

Strategic Considerations for Mitigating the Impact of COVID-19 on Key Population-Focused HIV Programs

One of the most prominent priorities during the COVID-19 pandemic is sustaining the gains toward HIV epidemic control and ensuring continuity of treatment and support for viral suppression among people living with HIV (PLHIV), including members of key populations (KPs).
Include in home page features rotation
Off

People's Country Operational Plan on HIV and TB (People's COP19)

With only a year until 2020 – and the deadline to reach the 90-90-90 targets – South Africa is dangerously off track. Currently 7.1 million people are living with HIV in the country. New HIV infections remain high, according to the Thembisa model1 at 275 000 in 2017, higher than the 231 000 estimated in the Human Sciences Research Council (HSRC) survey.

Include in home page features rotation
Off

Conference on Retroviruses and Opportunistic Infections (CROI 2019)

Venue
Seattle, Washington, USA

The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI 2019 will be held from March 4 to March 7, 2019, at the Washington State Convention Center in Seattle, Washington.

Include in home page features rotation
Off

Associated factors with unsuccessful tuberculosis treatment outcomes among tuberculosis/HIV coinfected patients with drug-resistant tuberculosis

Author
Azeez, A., et al.

BACKGROUND: In Sub-Saharan Africa, HIV endemic has substantially contributed to the increasing tuberculosis (TB) incidence. The joint effect of the HIV and TB pestilences has confronted the feeble systems of healthcare in resource-limited countries.

Include in home page features rotation
Off

9th SA AIDS Conference 2019

Venue
Durban, South Africa
The 9th South African AIDS Conference will focus on scientific, social and digital innovations which could expand possibilities and opportunities towards controlling the HIV & AIDS epidemic. The conference will determine how contemporary explosive and disruptive technologies will contribute towards sustained HIV prevention efforts, HIV testing, ART uptake and adherence, trigger the development of new drugs, effectively utilise enormous volumes of data and improve communication and service delivery and eventually end the epidemic.
Include in home page features rotation
Off

INTEREST - 13th International Conference on HIV Treatment, Pathogenesis, and Prevention Research in Resource-Limited Settings

Venue
Accra, Ghana

Known as the “African CROI” the INTEREST Conference brings together scientists involved in HIV treatment, pathogenesis, and prevention research in Africa to share pivotal findings, promote collaboration, and transfer experiences across several fields and many continents. The conference will showcase cutting-edge knowledge in the diagnosis and treatment of HIV and the prevention of the HIV-1 infection.

Include in home page features rotation
Off
Subscribe to co-infections